FMS vs LH
Fresenius Medical Care AG and Labcorp Holdings Inc., side by side — 7 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | FMS | LH |
|---|---|---|
| Revenue | $14.6B | $14.0B |
| Net income | $1.1B | $876.5M |
| Gross margin | 32.4% | 28.8% |
| Net margin | 8.6% | 6.3% |
| Return on equity | 12.2% | 10.5% |
| Diluted EPS | $3.65 | $10.46 |
| Dividend / share | · | $2.88 |
| Payout ratio | 26.7% | 27.5% |
| Free cash flow | $1.3B | $1.2B |
| Equity | $9.2B | $8.6B |
| Net debt / equity | 0.78× | 0.59× |
| Current ratio | 1.77× | 1.42× |
| Revenue CAGR 5y | 6.6% | −0.0% |
| Profit CAGR 5y | 6.3% | −10.8% |
FMS and LH book revenue within 15% of each other, and keeps more of each dollar of revenue as profit (8.6% against 6.3%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
7 years side by side
| Fiscal year | FMS | LH |
|---|---|---|
| FY2013 | $14.6B | $5.8B |
| FY2012 | $13.8B | $5.7B |
| FY2011 | $12.6B | $5.5B |
| FY2010 | $11.8B | $5.0B |
| FY2009 | $11.2B | $4.7B |
| FY2008 | $10.6B | $4.5B |
| FY2007 | $9.7B | $4.1B |
Bottom line
| Fiscal year | FMS | LH |
|---|---|---|
| FY2013 | $1.1B | $573.8M |
| FY2012 | $1.2B | $583.1M |
| FY2011 | $1.1B | $519.7M |
| FY2010 | $978.5M | $558.2M |
| FY2009 | $891.1M | $543.3M |
| FY2008 | $817.6M | $464.5M |
| FY2007 | $717.1M | $476.8M |
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2013 | +$8,801,427,000 | FMS |
| FY2012 | +$8,128,882,000 | FMS |
| FY2011 | +$7,028,215,000 | FMS |
| FY2010 | +$6,840,294,000 | FMS |
| FY2009 | +$6,552,777,000 | FMS |
| FY2008 | +$6,107,123,000 | FMS |
| FY2007 | +$5,652,114,000 | FMS |
FMS has reported the higher revenue in every one of these 7 fiscal years. The gap has widened since the earliest year compared.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2013 | −1.3 pp | LH |
| FY2012 | −0.7 pp | LH |
| FY2011 | −0.3 pp | LH |
| FY2010 | −2.4 pp | LH |
| FY2009 | −3.3 pp | LH |
| FY2008 | −2.5 pp | LH |
| FY2007 | −3.9 pp | LH |
LH has kept the higher net margin in every one of these 7 fiscal years.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
LH's net margin has been more volatile than FMS's over the 7 comparable fiscal years — 0.8 percentage points of standard deviation against 0.6.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
LH led in net margin in every one of the 7 comparable fiscal years — a structural lead, not a recent swing.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
LH's return on equity has been more volatile than FMS's over the 7 comparable fiscal years — 5.2 percentage points of standard deviation against 0.7.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
LH led in return on equity in every one of the 7 comparable fiscal years — a structural lead, not a recent swing.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.